Gain-of-function human UNC93B1 variants cause systemic lupus erythematosus and chilblain lupus.


Journal

The Journal of experimental medicine
ISSN: 1540-9538
Titre abrégé: J Exp Med
Pays: United States
ID NLM: 2985109R

Informations de publication

Date de publication:
05 Aug 2024
Historique:
received: 10 11 2023
revised: 29 03 2024
accepted: 15 05 2024
medline: 13 6 2024
pubmed: 13 6 2024
entrez: 13 6 2024
Statut: ppublish

Résumé

UNC93B1 is a transmembrane domain protein mediating the signaling of endosomal Toll-like receptors (TLRs). We report five families harboring rare missense substitutions (I317M, G325C, L330R, R466S, and R525P) in UNC93B1 causing systemic lupus erythematosus (SLE) or chilblain lupus (CBL) as either autosomal dominant or autosomal recessive traits. As for a D34A mutation causing murine lupus, we recorded a gain of TLR7 and, to a lesser extent, TLR8 activity with the I317M (in vitro) and G325C (in vitro and ex vivo) variants in the context of SLE. Contrastingly, in three families segregating CBL, the L330R, R466S, and R525P variants were isomorphic with respect to TLR7 activity in vitro and, for R525P, ex vivo. Rather, these variants demonstrated a gain of TLR8 activity. We observed enhanced interaction of the G325C, L330R, and R466S variants with TLR8, but not the R525P substitution, indicating different disease mechanisms. Overall, these observations suggest that UNC93B1 mutations cause monogenic SLE or CBL due to differentially enhanced TLR7 and TLR8 signaling.

Identifiants

pubmed: 38869500
pii: 276809
doi: 10.1084/jem.20232066
pii:
doi:

Substances chimiques

Toll-Like Receptor 7 0
UNC93B1 protein, human 0
Membrane Transport Proteins 0
Toll-Like Receptor 8 0
TLR7 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Fondation pour la Recherche Médicale
ID : FDM202106013329
Organisme : European Research Council
ID : 786142 E-T1IFNs
Pays : International
Organisme : Medical Research Council
ID : MC_UU_00035/11
Pays : United Kingdom
Organisme : Agence Nationale de la Recherche
ID : ANR-10-IAHU-01
Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : Rockefeller University
Organisme : St. Giles Foundation
Organisme : French Foundation for Medical Research
ID : EQU201903007798
Organisme : European Union's Horizon 2020 research and innovation program
ID : 824110
Organisme : Square Foundation
Organisme : Grandir-Fonds de solidarité pour l'enfance
Organisme : General Atlantic Foundation
Organisme : Institut National de la Santé et de la Recherche Médicale
Organisme : Paris Cité University
Organisme : European Molecular Biology Organization

Informations de copyright

© 2024 David et al.

Auteurs

Clémence David (C)

Laboratory of Neurogenetics and Neuroinflammation, Imagine Institute, INSERM UMR1163, Paris, France.

Carlos A Arango-Franco (CA)

Laboratory of Human Genetics of Infectious Diseases, INSERM UMR1163, Necker Hospital for Sick Children, Paris, France.
Department of Microbiology and Parasitology, Group of Primary Immunodeficiencies, School of Medicine, University of Antioquia, Medellín, Colombia.

Mihaly Badonyi (M)

MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh , Edinburgh, UK.

Julien Fouchet (J)

Faculté de Médecine Necker, Institut Necker Enfants Malades, INSERM U1151-CNRS UMR 8253, Université Paris Cité, Paris, France.

Gillian I Rice (GI)

Faculty of Biology, Medicine and Health, Division of Evolution and Genomic Sciences, School of Biological Sciences, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.

Blaise Didry-Barca (B)

Laboratory of Neurogenetics and Neuroinflammation, Imagine Institute, INSERM UMR1163, Paris, France.

Lucie Maisonneuve (L)

Faculté de Médecine Necker, Institut Necker Enfants Malades, INSERM U1151-CNRS UMR 8253, Université Paris Cité, Paris, France.

Luis Seabra (L)

Laboratory of Neurogenetics and Neuroinflammation, Imagine Institute, INSERM UMR1163, Paris, France.

Robin Kechiche (R)

Laboratory of Neurogenetics and Neuroinflammation, Imagine Institute, INSERM UMR1163, Paris, France.
Department of Paediatric Hematology-Immunology and Rheumatology, Necker-Enfants Malades Hospital, Assistance publique-hôpitaux de Paris (AP-HP), Paris, France.

Cécile Masson (C)

Bioinformatics Core Facility, Université Paris Cité-Structure Fédérative de Recherche Necker, INSERM US24/CNRS UMS3633, Paris, France.

Aurélie Cobat (A)

Laboratory of Human Genetics of Infectious Diseases, INSERM UMR1163, Necker Hospital for Sick Children, Paris, France.
St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
Imagine Institute, Université Paris Cité , Paris, France.

Laurent Abel (L)

Laboratory of Human Genetics of Infectious Diseases, INSERM UMR1163, Necker Hospital for Sick Children, Paris, France.
St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
Imagine Institute, Université Paris Cité , Paris, France.

Estelle Talouarn (E)

Laboratory of Human Genetics of Infectious Diseases, INSERM UMR1163, Necker Hospital for Sick Children, Paris, France.
Imagine Institute, Université Paris Cité , Paris, France.

Vivien Béziat (V)

Laboratory of Human Genetics of Infectious Diseases, INSERM UMR1163, Necker Hospital for Sick Children, Paris, France.
St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
Imagine Institute, Université Paris Cité , Paris, France.

Caroline Deswarte (C)

Laboratory of Human Genetics of Infectious Diseases, INSERM UMR1163, Necker Hospital for Sick Children, Paris, France.
Imagine Institute, Université Paris Cité , Paris, France.

Katie Livingstone (K)

MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh , Edinburgh, UK.

Carle Paul (C)

Université Toulouse Paul Sabatier , Toulouse, France.

Gulshan Malik (G)

Paediatric Rheumatology, Royal Aberdeen Children's Hospital, Aberdeen, UK.

Alison Ross (A)

Paediatric Rheumatology, Royal Aberdeen Children's Hospital, Aberdeen, UK.

Jane Adam (J)

Paediatric Rheumatology, Royal Aberdeen Children's Hospital, Aberdeen, UK.

Jo Walsh (J)

Department of Paediatric Rheumatology, Royal Hospital for Children, Glasgow, UK.

Sathish Kumar (S)

Department of Pediatrics, Pediatric Rheumatology, Christian Medical College, Vellore, India.

Damien Bonnet (D)

Medical and Surgical Unit of Congenital and Paediatric Cardiology, Reference Centre for Complex Congenital Heart Defects-M3C, University Hospital Necker-Enfants Malades, Paris, France.
Université Paris Cité , Paris, France.

Christine Bodemer (C)

Department of Dermatology, Hospital Necker-Enfants Malades, AP-HP. Université Paris Cité, Paris, France.

Brigitte Bader-Meunier (B)

Department of Paediatric Hematology-Immunology and Rheumatology, Necker-Enfants Malades Hospital, Assistance publique-hôpitaux de Paris (AP-HP), Paris, France.
Centre for Inflammatory Rheumatism, AutoImmune Diseases and Systemic Interferonopathies in Children (RAISE) , Paris, France.

Joseph A Marsh (JA)

MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh , Edinburgh, UK.

Jean-Laurent Casanova (JL)

Laboratory of Human Genetics of Infectious Diseases, INSERM UMR1163, Necker Hospital for Sick Children, Paris, France.
St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
Imagine Institute, Université Paris Cité , Paris, France.
Howard Hughes Medical Institute , New York, NY, USA.
Department of Pediatrics, Necker Hospital for Sick Children, Paris, France.

Yanick J Crow (YJ)

Laboratory of Neurogenetics and Neuroinflammation, Imagine Institute, INSERM UMR1163, Paris, France.
MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh , Edinburgh, UK.
Université Paris Cité , Paris, France.

Bénédicte Manoury (B)

Faculté de Médecine Necker, Institut Necker Enfants Malades, INSERM U1151-CNRS UMR 8253, Université Paris Cité, Paris, France.

Marie-Louise Frémond (ML)

Laboratory of Neurogenetics and Neuroinflammation, Imagine Institute, INSERM UMR1163, Paris, France.
Department of Paediatric Hematology-Immunology and Rheumatology, Necker-Enfants Malades Hospital, Assistance publique-hôpitaux de Paris (AP-HP), Paris, France.
Centre for Inflammatory Rheumatism, AutoImmune Diseases and Systemic Interferonopathies in Children (RAISE) , Paris, France.

Jonathan Bohlen (J)

Laboratory of Human Genetics of Infectious Diseases, INSERM UMR1163, Necker Hospital for Sick Children, Paris, France.
Imagine Institute, Université Paris Cité , Paris, France.

Alice Lepelley (A)

Laboratory of Neurogenetics and Neuroinflammation, Imagine Institute, INSERM UMR1163, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH